Cargando…

Adoptively transferred tumor-infiltrating T cells target somatic cancer mutations in a human papillomavirus+ cancer patient with complete tumor regression

Detalles Bibliográficos
Autores principales:	Stevanović, Sanja, Anna, Pasetto, Gartner, Jared J, Tran, Eric, Robbins, Paul F, Rosenberg, Steven A, Hinrichs, Christian S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645447/ http://dx.doi.org/10.1186/2051-1426-3-S2-P52

Ejemplares similares

Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
por: Hinrichs, Christian S, et al.
Publicado: (2013)

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer
por: Deniger, Drew C, et al.
Publicado: (2015)

Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
por: Hanada, Ken-ichi, et al.
Publicado: (2015)

Durable complete response in a patient with metastatic melanoma following adoptive transfer of autologous T cells recognizing 10 mutated tumor antigens
por: Prickett, Todd D, et al.
Publicado: (2015)

Use of CD137 up-regulation to identify T cell receptors specifically reactive with mutated tumor associated antigens from tumor infiltrating lymphocytes
por: Parkhurst, Maria, et al.
Publicado: (2015)

Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells
por: Robbins, Paul F., et al.
Publicado: (2013)

T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
por: Doran, Stacey L., et al.
Publicado: (2019)

Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer
por: Lee, Hee Jin, et al.
Publicado: (2017)

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
por: Rohaan, Maartje W., et al.
Publicado: (2018)

Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer
por: Zhu, Yahui, et al.
Publicado: (2022)

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
por: Gros, Alena, et al.
Publicado: (2015)

Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial Design
por: Helman, Sarah R., et al.
Publicado: (2018)

Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
por: Crystal, Jessica S, et al.
Publicado: (2015)

Specific recognition of an FGFR2 fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma
por: White, Bradley Sinclair, et al.
Publicado: (2023)

IL-12 stimuli during ex vivo expansion not only prevents the upregulation of PD1 on tumor infiltrating adoptively transferred T cells but also on endogenous TILs which results in effective tumor regression
por: Diaz-Montero, C Marcela, et al.
Publicado: (2014)

Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
por: Kim, Sanghyun P., et al.
Publicado: (2022)

Toward cell transfer immunotherapy against patient-specific mutations in gastrointestinal cancers
por: Tran, Eric, et al.
Publicado: (2014)

Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome
por: Wang, Linan, et al.
Publicado: (2016)

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2018)

The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
por: Li, Ruonan, et al.
Publicado: (2023)

Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
por: Mullinax, John E., et al.
Publicado: (2022)

Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma
por: Alvarez-Downing, Melissa M, et al.
Publicado: (2012)

“First AID” for T cell adoptive transfer: TCR affinity maturation by somatic hypermutation
por: Gozlan, Yosi M, et al.
Publicado: (2013)

Adoptively transferred melanoma-reactive CTL primed in the presence of IL-21 and transferred with concurrent CTLA4 blockade results in enhanced CTL persistence and tumor regression
por: Yee, Cassian, et al.
Publicado: (2014)

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy
por: Yunger, Sharon, et al.
Publicado: (2019)

Improving the outcome of adoptive cell transfer by targeting tumor escape
por: Kaluza, Karen M., et al.
Publicado: (2013)

Tetramer based approach for efficient identification and isolation of neo-antigen specific CD8 T cells from peripheral blood (PBL) of patients with metastatic cancers
por: Bharathan, Mini, et al.
Publicado: (2015)

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
por: Kverneland, Anders Handrup, et al.
Publicado: (2021)

Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy
por: Kodumudi, Krithika N., et al.
Publicado: (2016)

Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes
por: Orcurto, Angela, et al.
Publicado: (2020)

Oncolytic Virus Promotes Tumor-Reactive Infiltrating Lymphocytes for Adoptive Cell Therapy
por: Feist, Mathilde, et al.
Publicado: (2021)

CpG Oligodeoxynucleotides Enhance the Efficacy of Adoptive Cell Transfer Using Tumor Infiltrating Lymphocytes by Modifying the Th1 Polarization and Local Infiltration of Th17 Cells
por: Xu, Lin, et al.
Publicado: (2010)

Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer
por: Fereydouni, Mohammad, et al.
Publicado: (2022)

Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth
por: Bolpetti, Aline, et al.
Publicado: (2010)

Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment
por: Füchsl, Franziska, et al.
Publicado: (2022)

Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression
por: Kudling, Tatiana V., et al.
Publicado: (2022)

Somatic mutations in leukocytes infiltrating primary breast cancers
por: Kleppe, Maria, et al.
Publicado: (2015)

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
por: Mullinax, John E., et al.
Publicado: (2018)

Profiles of Tumor-Infiltrating Lymphocytes in a Case of Trichilemmal Carcinoma with Spontaneous Regression
por: Furudate, Sadanori, et al.
Publicado: (2012)

Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation
por: Prickett, Todd D., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b9ulnu1hgbfckrsh5u9ngns6mq